Toxicity-related T-DXd discontinuation was 15%, closely aligning with DESTINY-Breast04 (16.2%), supporting feasibility of administration in community oncology despite higher real-world disease burden.

Findings from a phase 1/2 trial (NCT04176) presented at the 2025 American Society of Hematology Annual Meeting and Exposition ...

Ozempic is intended to help people with diabetes manage blood sugar. A dietitian breaks down exactly what Ozempic is, and if ...

A 2026 informational consumer research report examining the TMates telehealth weight-loss platform, compounded GLP-1 ...

Adding flaxseeds to your daily diet may help lower blood pressure, with even greater benefits in people with hypertension.

Real-world data show that Enhertu (fam-trastuzumab deruxtecan-nxki) was tolerated as well in the community setting, where patients had higher disease burden, as in the clinical trial setting, ...

Transitioning a heifer calf into a productive, long-term member of the breeding herd requires attention to many important ...

Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company focused on providing therapies for people living with rare disease, today reported its financial results ...

When cows develop mastitis, dairies often respond with immediate antibiotic treatment. That approach has long protected ...

RDX-002 resulted in 57% less weight regain after GLP-1 therapy, showing promise as a durable and well-tolerated weight management option.

As announced, Jaguar received an up-front payment of $16M of non-dilutive capital in January 2026 upon entering U.S.

This press release is intended for US audiences for transparency relative to global news for the Fabry community. This dosing regimen for ...